Citations (169)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Antonio Lopez-Beltran. (2008) Bladder cancer: Clinical and pathological profile. Scandinavian Journal of Urology and Nephrology 42:sup218, pages 95-109.
Read now
Read now
Somali Sanyal, Charlotta Ryk, Petra J. De Verdier, Gunnar Steineck, Per Larsson, Erik Onelöv, Kari Hemminki & Rajiv Kumar. (2007) Polymorphisms in NQO1 and the clinical course of urinary bladder neoplasms. Scandinavian Journal of Urology and Nephrology 41:3, pages 182-190.
Read now
Read now
Ingo Kausch, Christian Doehn & Dieter Jocham. (2006) Recent improvements in the detection and treatment of nonmuscle-invasive bladder cancer. Expert Review of Anticancer Therapy 6:9, pages 1301-1311.
Read now
Read now
Antonio Lopez‐Beltran & Liang Cheng. (2003) Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance. Pathology 35:6, pages 484-491.
Read now
Read now
Kyoichi Tomita*Adrie van Bokhoven†Cornelius F.J. Jansen, Lambertus A. Kiemeney, Herbert F.M. Karthaus, Jessica Vriesema, Marion J.G. Bussemakers, J. Alfred Witjes & Jack A. Schalken. (2003) Activated Leukocyte Cell Adhesion Molecule (ALCAM) Expression is Associated with a Poor Prognosis for Bladder Cancer Patients. UroOncology 3:3-4, pages 121-129.
Read now
Read now
Per Larsson, Hans Wijkström, Andreas Thorstenson, Jan Adolfsson, Ulf Norming, Peter Wiklund, Erik Onelöv & Gunnar Steineck. (2003) A Population-based Study of 538 Patients with Newly Detected Urinary Bladder Neoplasms Followed during 5 Years. Scandinavian Journal of Urology and Nephrology 37:3, pages 195-201.
Read now
Read now
Athanase Billis, Rita B. Carvalho, Amilcar C. Mattos, Fábio Negretti, Cintia R. Nogueira, Monica C. B. M. Oliveira, José T. Valença Jr, Randall L. Adam, Ana C. S. Cotta, Mônica S. Nunes, Paula V. V. Dinamarco. (2001) Tumor Grade Heterogeneity in Urothelial Bladder Carcinoma?Proposal of a System Using Combined Numbers. Scandinavian Journal of Urology and Nephrology 35:4, pages 275-279.
Read now
Read now
Sten Holmäng, Sonny L. Johansson. (2001) The Nested Variant of Transitional Cell Carcinoma - A Rare Neoplasm with Poor Prognosis. Scandinavian Journal of Urology and Nephrology 35:2, pages 102-105.
Read now
Read now
Sten Holmäng, Hans Hedelin, Claes Anderström, Erik Holmberg & Sonny L. Johansson. (2000) Prospective Registration of all Patients in a Geographical Region with Newly Diagnosed Bladder Carcinomas during a Two-year Period. Scandinavian Journal of Urology and Nephrology 34:2, pages 95-101.
Read now
Read now
J. Hugosson, S. Bergdahl, G. Carlsson, R. Frösing, L. Norlén & B. Gustavsson. (1997) Effects of Intravesical Instillation of 5-Fluorouracil and Interferon in Patients with Recurrent Superficial Urinary Bladder Carcinoma: A Clinical and Pharmacodynamic Study. Scandinavian Journal of Urology and Nephrology 31:4, pages 343-347.
Read now
Read now
E. Rintala, E. Hannisdahl, S. D. Fosså, S. Hellsten & S. Sander. (1993) Neoadjuvant Chemotherapy in Bladder Cancer: A Randomized Study. Scandinavian Journal of Urology and Nephrology 27:3, pages 355-362.
Read now
Read now
Sophie D. Fosså, Sigurd Ous, Sissi Espetveit & Frøydis Langmark. (1992) Patterns of Primary Care and Survival in 336 Consecutive Unselected Norwegian Patients With Bladder Cancer. Scandinavian Journal of Urology and Nephrology 26:2, pages 131-138.
Read now
Read now
Per-Uno Malmström, Christer Busch, Bo Johan Norlen & Bertil Andersson. (1988) Expression of ABH Blood Group Isoantigen as a Prognostic Factor in Transitional Cell Bladder Carcinoma. Scandinavian Journal of Urology and Nephrology 22:4, pages 265-270.
Read now
Read now
Articles from other publishers (156)
Benjamin H. Rudnik, Scott G. Hubosky, Kim HooKim, Demetrius H. Bagley, María Rodríguez-Monsalve, Etienne Xavier Keller, Vincent De Coninck, Olivier Traxer, Michael GrassoIIIIII, Nitin Sharma, Andrew I. Fishman, Joseph K. Izes & Anna W. Komorowski. 2022. Advanced Ureteroscopy. Advanced Ureteroscopy
155
207
.
John N. Eble, Pedram Argani, David J. Grignon & Liang Cheng. 2021. Tumors of the Kidney, Bladder, and Related Urinary Structures. Tumors of the Kidney, Bladder, and Related Urinary Structures
345
559
.
Wesley H. Chou, Bradley McGregor, Andrew Schmidt, Filipe L.F. Carvalho, Michelle S. Hirsch, Steven L. Chang, Adam Kibel & Matthew Mossanen. (2021) Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review. Urologic Oncology: Seminars and Original Investigations 39:10, pages 678-685.
Crossref
Crossref
Antonio Lopez-Beltran & Liang Cheng. (2021) Stage T1 bladder cancer: diagnostic criteria and pitfalls. Pathology 53:1, pages 67-85.
Crossref
Crossref
Ilaria Jansen, Marit Lucas, Judith Bosschieter, Onno J. de Boer, Sybren L. Meijer, Ton G. van Leeuwen, Henk A. Marquering, Jakko A. Nieuwenhuijzen, Daniel M. de Bruin & C. Dilara Savci-Heijink. (2020) Automated Detection and Grading of Non–Muscle-Invasive Urothelial Cell Carcinoma of the Bladder. The American Journal of Pathology 190:7, pages 1483-1490.
Crossref
Crossref
Liang Cheng, Antonio Lopez-Beltran, Gregory T. MacLennan, Rodolfo Montironi & David G. Bostwick. 2020. Urologic Surgical Pathology. Urologic Surgical Pathology
230
321.e19
.
Grzegorz Fojecki, Anders Magnusson, Olivier Traxer, Joyce Baard, Palle Jörn Sloth Osther, Georg Jaremko, Christian Seitz, Thomas Knoll, Guido Giusti & Marianne Brehmer. (2019) Consultation on UTUC, Stockholm 2018 aspects of diagnosis of upper tract urothelial carcinoma. World Journal of Urology 37:11, pages 2271-2278.
Crossref
Crossref
Eva M. Compérat, Maximilian Burger, Paolo Gontero, A. Hugh Mostafid, Joan Palou, Morgan Rouprêt, Bas W.G. van Rhijn, Shahrokh F. Shariat, Richard J. Sylvester, Richard Zigeuner & Marko Babjuk. (2019) Grading of Urothelial Carcinoma and The New “World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016”. European Urology Focus 5:3, pages 457-466.
Crossref
Crossref
Liqun Zhou, Kaiwei Yang, Xuesong Li, Yi Ding, Dawei Mu, Hanzhong Li, Yong Yan, Jinyi Li, Dongwen Wang, Wei Li, Yulong Cong, Jiangping Gao, Kewei Ma, Yajun Xiao, Sheng Zhang, Hongyi Jiang, Weilie Hu, Qiang Wei, Xunbo Jin, Zhichen Guan, Qingyong Liu, Danfeng Xu, Xin Gao, Yongguang Jiang, Weimin Gan, Guang Sun, Qing Wang, Yanhui Liu, Jianquan Hou, Liping Xie, Xishuang Song, Fengshuo Jin, Jiafu Feng, Ming Cai, Zhaozhao Liang, Jie Zhang, Dingwei Ye, Lin Qi, Lulin Ma, Jianzhong Shou, Yuping Dai, Jianyong Shao, Ye Tian, Shizhe Hong, Tao Xu, Chuize Kong, Zefeng Kang, Yuexin Liu, Xun Qu, Benkang Shi, Shaobin Zheng, Yi Lin, Shujie Xia, Dong Wei, Jianbo Wu, Weiling Fu, Zhiping Wang & Jianbo Liang. (2019) Application of fluorescence in situ hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population. Asian Journal of Urology 6:1, pages 114-121.
Crossref
Crossref
A. N. Srivastava, Kirti A. Gautam & S. N. Sankhwar. 2019. Molecular Diagnostics in Cancer Patients. Molecular Diagnostics in Cancer Patients
219
235
.
Elizabeth L. Kehr & Justine A. Barletta. 2017. Pathology and Epidemiology of Cancer. Pathology and Epidemiology of Cancer
523
541
.
Robin T. Vollmer. (2016) A Review of Outcomes for Stage Ta Bladder Tumors. American Journal of Clinical Pathology 146:2, pages 215-220.
Crossref
Crossref
Xinchao Wu, Dong Liu, Dan Tao, Wei Xiang, Xingyuan Xiao, Miao Wang, Liang Wang, Gang Luo, Yawei Li, Fuqing Zeng & Guosong Jiang. (2016) BRD4 Regulates EZH2 Transcription through Upregulation of C-MYC and Represents a Novel Therapeutic Target in Bladder Cancer. Molecular Cancer Therapeutics 15:5, pages 1029-1042.
Crossref
Crossref
Deborah R. Kaye, Joseph K. Canner, Max Kates, Mark P. Schoenberg & Trinity J. Bivalacqua. (2016) Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a Difference. Bladder Cancer 2:2, pages 225-234.
Crossref
Crossref
Louis Lacombe, Vincent Fradet, Éric Lévesque, Frédéric Pouliot, Hélène Larue, Alain Bergeron, Hélène Hovington, André Caron, Molière Nguile-Makao, Mario Harvey, Yves Fradet & Chantal Guillemette. (2016) Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non–Muscle-Invasive Bladder Cancer: A Gene–Smoking Interaction. Cancer Prevention Research 9:2, pages 189-195.
Crossref
Crossref
Jason A. Efstathiou & Anthony L. Zietman. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology
1096
1120.e6
.
Elisabeth E. Fransen van de Putte, Mark A. Behrendt, Garry L.S. Pigot, Theo H. van der Kwast & Bas W.G. van Rhijn. (2015) Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder. Current Opinion in Urology 25:5, pages 427-435.
Crossref
Crossref
Mahul B Amin, Steven C Smith, Victor E Reuter, Jonathan I Epstein, David J Grignon, Donna E Hansel, Oscar Lin, Jesse K McKenney, Rodolfo Montironi, Gladell P Paner, Hikmat A Al-Ahmadie, Ferran Algaba, Syed Ali, Isabel Alvarado-Cabrero, Lukas Bubendorf, Liang Cheng, John C Cheville, Glen Kristiansen, Richard J Cote, Brett Delahunt, John N Eble, Elizabeth M Genega, Christian Gulmann, Arndt Hartmann, Cord Langner, Antonio Lopez-Beltran, Cristina Magi-Galluzzi, Jorda Merce, George J Netto, Esther Oliva, Priya Rao, Jae Y Ro, John R Srigley, Satish K Tickoo, Toyonori Tsuzuki, Saleem A Umar, Theo Van der Kwast, Robert H Young & Mark S Soloway. (2015) Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer. Modern Pathology 28:5, pages 612-630.
Crossref
Crossref
Bas W G van Rhijn, Mireia Musquera, Liyang Liu, André N Vis, Tahlita C M Zuiverloon, Geert J L H van Leenders, Wim J Kirkels, Ellen C Zwarthoff, Egbert R Boevé, Adriaan C Jöbsis, Bharati Bapat, Michael A S Jewett, Alexandre R Zlotta & Theo H van der Kwast. (2015) Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications. Modern Pathology 28:5, pages 695-705.
Crossref
Crossref
Christopher S. Foster & George J. Netto. 2015. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology
2322
2412
.
Antonio Lopez-Beltran, Carmen L. Menendez, Rodolfo Montironi & Liang ChengAntonio Lopez-Beltran, Carmen L. Menendez, Rodolfo Montironi & Liang Cheng. 2015. Rare Tumors and Tumor-like Conditions in Urological Pathology. Rare Tumors and Tumor-like Conditions in Urological Pathology
63
194
.
Jesse K. McKenney. 2015. Genitourinary Pathology. Genitourinary Pathology
189
199
.
Jacob T. Ark, Kirk A. Keegan, Daniel A. Barocas, Todd M. Morgan, Matthew J. Resnick, Chaochen You, Michael S. Cookson, David F. Penson, Rodney Davis, Peter E. Clark, Joseph A. SmithJrJr & Sam S. Chang. (2014) Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy. BJU International 113:6, pages 894-899.
Crossref
Crossref
Naotaka Izumiyama-Shimomura, Ken-ichi Nakamura, Junko Aida, Naoshi Ishikawa, Mie Kuroiwa, Naoki Hiraishi, Mutsunori Fujiwara, Yuichi Ishikawa, Naoko Inoshita, Junji Yonese, Masaaki Matsuura, Steven S.S. Poon, Tomio Arai & Kaiyo Takubo. (2014) Short telomeres and chromosome instability prior to histologic malignant progression and cytogenetic aneuploidy in papillary urothelial neoplasms. Urologic Oncology: Seminars and Original Investigations 32:2, pages 135-145.
Crossref
Crossref
Chin-Chen Pan & Yen-Hwa Chang. (2013) The 2004 World Health Organization/International Society of Urological Pathology classification system for non-muscle-invasive bladder cancer. Urological Science 24:3, pages 96-100.
Crossref
Crossref
Mona Fahmy, Jose Joao Mansure, Fadi Brimo, Faysal A. Yafi, Robert Segal, Abdulaziz Althunayan, Jessica Hicks, Alan Meeker, George Netto & Wassim Kassouf. (2013) Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non–muscle invasive bladder cancer. Human Pathology 44:9, pages 1766-1772.
Crossref
Crossref
Liang Cheng, Gregory T. MacLennan & Antonio Lopez-Beltran. 2013. Cancer Grading Manual. Cancer Grading Manual
85
100
.
Liang Cheng, Gregory T. MacLennan & Antonio Lopez-Beltran. (2012) Histologic grading of urothelial carcinoma: a reappraisal. Human Pathology 43:12, pages 2097-2108.
Crossref
Crossref
Liang Cheng, Antonio Lopez‐Beltran & David G. Bostwick. 2012. Bladder Pathology. Bladder Pathology
161
191
.
D R Yates, V Hupertan, P Colin, A Ouzzane, A Descazeaud, J A Long, G Pignot, S Crouzet, F Rozet, Y Neuzillet, M Soulie, T Bodin, A Valeri, O Cussenot & M Rouprêt. (2012) Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram. British Journal of Cancer 106:6, pages 1083-1088.
Crossref
Crossref
Jason A. Efstathiou, Anthony L. Zietman, John J. Coen & William U. Shipley. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology
1099
1123
.
Antonio Lopez-Beltran, Ferran Algaba, Daniel M Berney, Liliane Boccon-Gibod, Philippe Camparo, David Griffiths, Gregor Mikuz, Rodolfo Montironi, Murali Varma & Lars Egevad. (2011) Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP). Histopathology 58:4, pages 579-585.
Crossref
Crossref
Nelson G. Ordóñez & Juan Rosai. 2011. Rosai and Ackerman's Surgical Pathology. Rosai and Ackerman's Surgical Pathology
1101
1286
.
Dengfeng Cao, Robin T. Vollmer, Jason Luly, Samay Jain, Timur M. Roytman, Charles W. Ferris & M'Liss Ann Hudson. (2010) Comparison of 2004 and 1973 World Health Organization Grading Systems and Their Relationship to Pathologic Staging for Predicting Long-term Prognosis in Patients With Urothelial Carcinoma. Urology 76:3, pages 593-599.
Crossref
Crossref
Eun-Jung Kim, Young-Suk Lee, Yong-June Kim, Min-Ju Kim, Yun-Sok Ha, Pildu Jeong, Ok-Jun Lee & Wun-Jae Kim. (2010) Clinical Implications and Prognostic Values of Topoisomerase-II Alpha Expression in Primary Non–muscle-invasive Bladder Cancer. Urology 75:6, pages 1516.e9-1516.e13.
Crossref
Crossref
Bas W.G. van Rhijn, Geert J.L.H. van Leenders, Bert C.M. Ooms, Wim J. Kirkels, Alexandre R. Zlotta, Egbert R. Boevé, Adriaan C. Jöbsis & Theo H. van der Kwast. (2010) The Pathologist’s Mean Grade Is Constant and Individualizes the Prognostic Value of Bladder Cancer Grading. European Urology 57:6, pages 1052-1057.
Crossref
Crossref
JONATHAN I. EPSTEIN. 2010. Robbins and Cotran Pathologic Basis of Disease. Robbins and Cotran Pathologic Basis of Disease
971
1004
.
Akira Komiya, Takumi Endo, Masayuki Kobayashi, Woojin Kim, Kazuhiro Araki, Yukio Naya, Hiroyoshi Suzuki, Toyofusa Tobe, Tomohiko Ichikawa & Hideki Fuse. (2009) Oral analgesia by non-steroidal anti-inflammatory drug zaltoprofen to manage cystoscopy-related pain: A prospective study. International Journal of Urology 16:11, pages 874-880.
Crossref
Crossref
Udai S. Dwivedi, Abhay Kumar, Suren K. Das, Sameer Trivedi, Mohan Kumar, Shyam Sunder & Pratap B. Singh. (2009) Relook TURBT in superficial bladder cancer: Its importance and its correlation with the tumor ploidy. Urologic Oncology: Seminars and Original Investigations 27:5, pages 514-519.
Crossref
Crossref
David J Grignon. (2009) The current classification of urothelial neoplasms. Modern Pathology 22, pages S60-S69.
Crossref
Crossref
Bernard Têtu. (2009) Diagnosis of urothelial carcinoma from urine. Modern Pathology 22, pages S53-S59.
Crossref
Crossref
Rodolfo Montironi, Antonio Lopez-Beltran, Marina Scarpelli, Roberta Mazzucchelli & Liang Cheng. (2009) 2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections. European Urology Supplements 8:5, pages 453-457.
Crossref
Crossref
R Montironi, A Lopez-Beltran, M Scarpelli, R Mazzucchelli & L Cheng. (2008) Morphological classification and definition of benign, preneoplastic and non-invasive neoplastic lesions of the urinary bladder. Histopathology 53:6, pages 621-633.
Crossref
Crossref
Paolo Emiliozzi, Alberto Pansadoro & Vito Pansadoro. (2008) The optimal management of T1G3 bladder cancer. BJU International 102:9b, pages 1265-1273.
Crossref
Crossref
İpek Işık Gönül, Nalan Akyürek, Ayşe Dursun & Bora Küpeli. (2008) Relationship of Ki67, TP53, MDM-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades, tumor category and overall patient survival in urothelial tumors of the bladder. Pathology - Research and Practice 204:10, pages 707-717.
Crossref
Crossref
C. Fiorito, I. Lucca, M. Oderda, P. Mondino, G. Berta, E.A. Cattaneo, F. Valentino, A. Zitella, D. Pacchioni & A. Tizzani. (2018) Neuroendocrine bladder cancer: oncological emergency?. Urologia Journal 75:1, pages 57-61.
Crossref
Crossref
Liang Cheng, Antonio Lopez-Beltran, Gregory T. MacLennan, Rodolfo Montironi & David G. Bostwick. 2008. Urologic Surgical Pathology. Urologic Surgical Pathology
258
351
.
. 2008. Questions in Daily Urologic Practice. Questions in Daily Urologic Practice
163
173
.
Yvonne Förster & Bernd Schwenzer. 2008. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy. Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
337
362
.
I. Kausch & D. Jocham. (2007) Stellenwert der transurethralen Resektion und Instillationstherapie beim HarnblasenkarzinomSignificance of transurethral resection and instillation therapy in bladder cancer. Der Onkologe 13:12, pages 1080-1088.
Crossref
Crossref
Patrik Andius, Sonny L. Johansson & Sten Holmäng. (2007) Prognostic Factors in Stage T1 Bladder Cancer: Tumor Pattern (Solid or Papillary) and Vascular Invasion More Important than Depth of Invasion. Urology 70:4, pages 758-762.
Crossref
Crossref
Masayuki Kamada, Alan So, Mototsugu Muramaki, Palma Rocchi, Eliana Beraldi & Martin Gleave. (2007) Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells. Molecular Cancer Therapeutics 6:1, pages 299-308.
Crossref
Crossref
Cristina Magi-Galluzzi, Ming Zhou & Jonathan I. Epstein. 2007. Genitourinary Pathology. Genitourinary Pathology
154
224
.
Jeremy L. Ockrim & Paul D. Abel. 2007. Urological Cancers in Clinical Practice. Urological Cancers in Clinical Practice
75
101
.
Michele Pavone-Macaluso, Antonio Lopez-Beltran, Federico Aragona, Pierfrancesco Bassi & John M. Fitzpatrick. (2006) The pathology of bladder cancer: an update on selected issues. BJU International 98:6, pages 1161-1165.
Crossref
Crossref
José I. López, Javier González & Javier Angulo. (2006) Expresión de pRb, p53 y bcl-2 en el carcinoma de células transicionales de bajo grado no infiltrante (pTa) de la vejiga urinaria. Revista Española de Patología 39:3, pages 149-154.
Crossref
Crossref
HYUNG-JEE KIM, INHO SOHNG, CHEOL-HO HWANG & JI-YOUNG PARK. (2006) Cytokeratin-20 and seminal vesicle secretory protein VI as possible marker proteins in urinary bladder preneoplastic lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. International Journal of Urology 13:2, pages 142-147.
Crossref
Crossref
James W.F. Catto, Maysam F. Abbod, Derek A. Linkens & Freddie C. Hamdy. (2006) Neuro-Fuzzy Modeling: An Accurate and Interpretable Method for Predicting Bladder Cancer Progression. Journal of Urology 175:2, pages 474-479.
Crossref
Crossref
. (2005) Correct answers to multiple choice questions appearing in the European Urology Update Series 2005. BJU International 96:8, pages 1193-1208.
Crossref
Crossref
Thomas-Alexander Vogeli. (2005) The management of superficial transitional cell carcinoma of the bladder: a critical assessment of contemporary concepts and future perspectives. BJU International 96:8, pages 1171-1176.
Crossref
Crossref
Alan So, Palma Rocchi & Martin Gleave. (2005) Antisense oligonucleotide therapy in the management of bladder cancer. Current Opinion in Urology 15:5, pages 320-327.
Crossref
Crossref
Isabel Alvarado-Cabrero, Francisca I. Sierra-Santiesteban, Alejandra Mantilla-Morales & Dulce Ma Hernández-Hernandez. (2005) Micropapillary carcinoma of the urothelial tract. Annals of Diagnostic Pathology 9:1, pages 1-5.
Crossref
Crossref
Bernard Têtu, Rabi Tiguert, François Harel & Yves Fradet. (2005) ImmunoCyt/uCyt+™ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma. Modern Pathology 18:1, pages 83-89.
Crossref
Crossref
S. Störkel. 2005. Blasenkarzinom. Blasenkarzinom
1
10
.
Jeremy L. Ockrim & Paul D. Abel. 2005. Urological Cancers. Urological Cancers
131
144
.
Stergios Moschos, Sai Varanasi & John M. Kirkwood. 2005. Cytokines and Cancer. Cytokines and Cancer
207
241
.
Hui Yin & Anthony S.-Y. Leong. (2004) Histologic Grading of Noninvasive Papillary Urothelial Tumors : Validation of the 1998 WHO/ISUP System by Immunophenotyping and Follow-up. American Journal of Clinical Pathology 121:5, pages 679-687.
Crossref
Crossref
Gerhard Jakse, Ferran Algaba, Per-Uno Malmström & Willem Oosterlinck. (2004) A Second-Look TUR in T1 Transitional Cell Carcinoma: Why?. European Urology 45:5, pages 539-546.
Crossref
Crossref
George R. ProutJr.Jr., Margaret N. Wesley, Peter G. McCarron, Vivien W. Chen, Raymond S. Greenberg, Robert M. Mayberry & Brenda K. Edwards. (2004) Survival experience of black patients and white patients with bladder carcinoma. Cancer 100:3, pages 621-630.
Crossref
Crossref
Radzisław Kordek. (2004) Klasyfikacje nowotworów pęcherza moczowego. Reports of Practical Oncology & Radiotherapy 9:5, pages 173-177.
Crossref
Crossref
Per-Uno Malmström. (2003) Intravesical therapy of superficial bladder cancer. Critical Reviews in Oncology/Hematology 47:2, pages 109-126.
Crossref
Crossref
Jonathan I. Epstein. (2003) The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement?. Critical Reviews in Oncology/Hematology 47:2, pages 83-89.
Crossref
Crossref
Rodolfo Montironi & Roberta Mazzucchelli. (2003) Preneoplastic Lesions and Conditions of the Urinary Bladder. EAU Update Series 1:2, pages 53-63.
Crossref
Crossref
T Otto, J Suhr & H Rübben. (2003) Is There a Need or an Evidence for Rebiopsying Patients after a First TUR. EAU Update Series 1:2, pages 87-90.
Crossref
Crossref
R.T. Bryan & D.M.A. Wallace. (2002) ‘Superficial’ bladder cancer – time to uncouple pT1 tumours from pTa tumours. BJU International 90:9, pages 846-852.
Crossref
Crossref
HANS BOMAN, HANS HEDELIN, STEFAN JACOBSSON & STEN HOLM??NG. (2002) Newly Diagnosed Bladder Cancer:. The Journal of Urology, pages 1955-1959.
Crossref
Crossref
HANS BOMAN, HANS HEDELIN, STEFAN JACOBSSON & STEN HOLMÄNG. (2002) Newly Diagnosed Bladder Cancer: The Relationship of Initial Symptoms, Degree of Microhematuria and Tumor Marker Status. Journal of Urology 168:5, pages 1955-1959.
Crossref
Crossref
Hemamali Samaratunga, Danil V Makarov & Jonathan I Epstein. (2002) Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology 60:2, pages 315-319.
Crossref
Crossref
STEN HOLM??NG & SONNY L. JOHANSSON. (2002) Stage Ta-T1 Bladder Cancer: The Relationship Between Findings At First Followup Cystoscopy And Subsequent Recurrence And Progression. The Journal of Urology, pages 1634-1637.
Crossref
Crossref
Sten Holmäng & Sonny L. Johansson. (2002) Stage Ta-T1 Bladder Cancer: The Relationship Between Findings At First Followup Cystoscopy And Subsequent Recurrence And Progression. Journal of Urology 167:4, pages 1634-1637.
Crossref
Crossref
J. L. Ockrim & P. D. Abe. 2002. Treatment Options in Urological Cancer. Treatment Options in Urological Cancer
118
137
.
Toshihiro Hisataki, Noriomi Miyao, Naoya Masumori, Atsushi Takahashi, Masahiro Yanase, Naoki Itoh & Taiji Tsukamoto. (2001) Risk factors for multiple intravesical recurrences of superficial bladder cancer. Urology 58:6, pages 935-939.
Crossref
Crossref
STEN HOLM??NG, PATRIK ANDIUS, HANS HEDELIN, KENNETH WESTER, CHRISTER BUSCH & SONNY L. JOHANSSON. (2001) STAGE PROGRESSION IN TA PAPILLARY UROTHELIAL TUMORS: RELATIONSHIP TO GRADE, IMMUNOHISTOCHEMICAL EXPRESSION OF TUMOR MARKERS, MITOTIC FREQUENCY AND DNA PLOIDY. The Journal of Urology, pages 1124-1130.
Crossref
Crossref
STEN HOLMÄNG, PATRIK ANDIUS, HANS HEDELIN, KENNETH WESTER, CHRISTER BUSCH & SONNY L. JOHANSSON. (2001) STAGE PROGRESSION IN TA PAPILLARY UROTHELIAL TUMORS: RELATIONSHIP TO GRADE, IMMUNOHISTOCHEMICAL EXPRESSION OF TUMOR MARKERS, MITOTIC FREQUENCY AND DNA PLOIDY. Journal of Urology 165:4, pages 1124-1130.
Crossref
Crossref
M. Arrizabalaga Moreno, J.I. García González, J. Díez Rodríguez, M.J. Pérez Garnelo, J. Navarro Sebastián, M. Castro Pita, B. Muñoz Delgado & P. Paniagua Andrés. (2001) Evolución y pronóstico a medio y largo plazo de los tumores vesicales superficiales. Actas Urológicas Españolas 25:10, pages 710-719.
Crossref
Crossref
J.L. Moyano calvo, J.M. Poyato galán, A. Ortíz gamiz, A. Molina carranza, J.J. Zerpa railey, H. Toro cepeda, D. Sánchez-barriga peña, J. Castiñeiras fernández, M. De miguel rodríguez & H. Galera davidson. (2001) Determinación de ploidía de adn mediante citometría de flujo, índice ki-67 y sobre-expresión de proteína p53 en 121 carcinomas superficiales de vejiga t1. estudio retrospectivo. 2ª parte: valor pronóstico y utilidad en la indicación de tratamiento profiláctico con bcg. Actas Urológicas Españolas 25:1, pages 32-45.
Crossref
Crossref
Sangeeta Desai, So Dug Lim, Rafael E Jimenez, Thomas Chun, Thomas E Keane, Jesse K McKenney, Angel Zavala-Pompa, Cynthia Cohen, Robert H Young & Mahul B Amin. (2000) Relationship of Cytokeratin 20 and CD44 Protein Expression with WHO/ISUP Grade in pTa and pT1 Papillary Urothelial Neoplasia. Modern Pathology 13:12, pages 1315-1323.
Crossref
Crossref
K.K.H Aben, J.A Witjes, J.A.A.M van Dijck, J.A Schalken, A.L.M Verbeek & L.A.L.M Kiemeney. (2000) Lower incidence of urothelial cell carcinoma due to the concept of a clonal origin. European Journal of Cancer 36:18, pages 2385-2389.
Crossref
Crossref
Rafael E. Jimenez, Edward Gheiler, Peter Oskanian, Rabbi Tiguert, Wael Sakr, David P. WoodJr.Jr., J. Edson Pontes & David J. Grignon. (2000) Grading the Invasive Component of Urothelial Carcinoma of the Bladder and Its Relationship With Progression-Free Survival. The American Journal of Surgical Pathology 24:7, pages 980-987.
Crossref
Crossref
M. BRAKE, H. LOERTZER, R. HORSCH & H. KELLER. (2000) RECURRENCE AND PROGRESSION OF STAGE T1, GRADE 3 TRANSITIONAL CELL CARCINOMA OF THE BLADDER FOLLOWING INTRAVESICAL IMMUNOTHERAPY WITH BACILLUS CALMETTE-GUERIN. The Journal of Urology, pages 1697-1701.
Crossref
Crossref
M. BRAKE, H. LOERTZER, R. HORSCH & H. KELLER. (2000) RECURRENCE AND PROGRESSION OF STAGE T1, GRADE 3 TRANSITIONAL CELL CARCINOMA OF THE BLADDER FOLLOWING INTRAVESICAL IMMUNOTHERAPY WITH BACILLUS CALMETTE-GUERIN. Journal of Urology 163:6, pages 1697-1701.
Crossref
Crossref
J. Wolter A. Oosterhuis, Rene F. M. Schapers, Maryska L. G. Janssen-Heijnen, A. Wim G. B. Smeets & Ruud P. E. Pauwels. (2000) MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder. Cancer 88:11, pages 2598-2605.
Crossref
Crossref
Liang Cheng, Roxann M. Neumann, Ajay Nehra, Bruce E. Spotts, Amy L. Weaver & David G. Bostwick. (2000) Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer 88:7, pages 1663-1670.
Crossref
Crossref
Ryoichi Oyasu. (2000) World Health Organization and International Society of Urological Pathology classification and two-number grading system of bladder tumors. Cancer 88:7, pages 1509-1512.
Crossref
Crossref
Adam Jones & Jeremy Crew. (2000) VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS CORRELATION WITH SUPERFICIAL BLADDER CANCER RECURRENCE RATES AND STAGE PROGRESSION. Urologic Clinics of North America 27:1, pages 191-197.
Crossref
Crossref
THIERRY LEBRET, DENIS BOHIN, ZAREH KASSARDJIAN, JEAN-MARIE HERVE, VINCENT MOLINIE, PHILIPPE BARRE, PIERRE-MARIE LUGAGNE & HENRY BOTTO. (2000) RECURRENCE, PROGRESSION AND SUCCESS IN STAGE TA GRADE 3 BLADDER TUMORS TREATED WITH LOW DOSE BACILLUS CALMETTE-GUERIN INSTILLATIONS. The Journal of Urology, pages 63.
Crossref
Crossref
M. De Miguel Rodríguez, H. Galera Davidson, J.L. Moyano Calvo, A. Ortiz Gamiz, J.M. Poyato Galán, E. Sánchez Sánchez, E. Blanco Palenciano, J.M. Arribas Rodríguez & J. Castiñeiras Fernández. (2000) Determinación de ploidía de adn mediante citometría de flujo, índice ki-67 y sobreexpresión de proteína p53 en 121 carcinomas superficiales de vejiga t1. estudio retrospectivo correlación con las variables clásicas. Actas Urológicas Españolas 24:10, pages 785-795.
Crossref
Crossref
J. Álvarez Kindelan, A. López Beltrán & M.J. Requena Tapia. (2000) Neoplasia papilar urotelial de bajo potencial maligno. Estudio retrospectivo. Actas Urológicas Españolas 24:9, pages 743-748.
Crossref
Crossref
THIERRY LEBRET, DENIS BOHIN, ZAREH KASSARDJIAN, JEAN-MARIE HERVE, VINCENT MOLINIE, PHILIPPE BARRE, PIERRE-MARIE LUGAGNE & HENRY BOTTO. (2000) RECURRENCE, PROGRESSION AND SUCCESS IN STAGE TA GRADE 3 BLADDER TUMORS TREATED WITH LOW DOSE BACILLUS CALMETTE-GUERIN INSTILLATIONS. Journal of Urology 163:1, pages 63-67.
Crossref
Crossref
PETER NYGREN, KATALIN CSÒKA, ROLF LARSSON, CHRISTER BUSCH, KENNETH WESTER & PER-UNO MALMSTRÖM. (1999) ACTIVITY OF STANDARD AND INVESTIGATIONAL CYTOTOXIC DRUGS IN PRIMARY CULTURES OF TUMOR CELLS FROM PATIENTS WITH KIDNEY AND URINARY BLADDER CARCINOMAS. Journal of Urology 162:6, pages 2200-2204.
Crossref
Crossref
Liang Cheng, Roxann M. Neumann & David G. Bostwick. (1999) Papillary urothelial neoplasms of low malignant potential. Cancer 86:10, pages 2102-2108.
Crossref
Crossref
Christian Pfister, Louis Lacombe, Marie Claude Vezina, Lynne Moore, Hélène Larue, Bernard Têtu, François Meyer & Yves Fradet. (1999) Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors. Human Pathology 30:11, pages 1350-1355.
Crossref
Crossref
Liang ChengRoxann M. NeumannAmy L. WeaverBruce E. SpottsDavid G. Bostwick. (1999) Predicting Cancer Progression in Patients With Stage T1 Bladder Carcinoma. Journal of Clinical Oncology 17:10, pages 3182-3187.
Crossref
Crossref
Liang Cheng, Amy L. Weaver, Roxann M. Neumann, Beth G. Scherer & David G. Bostwick. (1999) Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer. Cancer 86:6, pages 1035-1043.
Crossref
Crossref
STEN HOLMANG, HANS HEDELIN, CLAES ANDERSTROM, ERIK HOLMBERG, CHRISTER BUSCH & SONNY L. JOHANSSON. (1999) RECURRENCE AND PROGRESSION IN LOW GRADE PAPILLARY UROTHELIAL TUMORS. Journal of Urology 162:3 Part 1, pages 702-707.
Crossref
Crossref
K A Iczkowski, J H Shanks, W C Allsbrook, A Lopez‐Beltran, C G Pantazis, T R Collins, R W Wetherington & D G Bostwick. (2001) Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense γ‐enolase expression. Histopathology 35:2, pages 150-156.
Crossref
Crossref
Victor E. Reuter. (1999) BLADDER. Urologic Clinics of North America 26:3, pages 481-492.
Crossref
Crossref
CHRISTIAN PFISTER, JEAN MICHEL FLAMAN, FREDERICK DUNET, PHILIPPE GRISE & THIERRY FREBOURG. (1999) P53 MUTATIONS IN BLADDER TUMORS INACTIVATE THE TRANSACTIVATION OF THE P21 AND BAX GENES, AND HAVE A PREDICTIVE VALUE FOR THE CLINICAL OUTCOME AFTER BACILLUS CALMETTE-GUERIN THERAPY. Journal of Urology 162:1, pages 69-73.
Crossref
Crossref
Kristina Hotakainen, Susanna Lintula, Jakob Stenman, Erkki Rintala, Ossi Lindell & Ulf-H�kan Stenman. (1999) Detection of messenger RNA for the ?-subunit of chorionic gonadotropin in urinary cells from patients with transitional cell carcinoma of the bladder by reverse transcription-polymerase chain reaction. International Journal of Cancer 84:3, pages 304-308.
Crossref
Crossref
CHRISTIAN PFISTER, JEAN MICHEL FLAMAN, COSETTE MARTIN, PHILIPPE GRISE & THIERRY FREBOURG. (1999) SELECTIVE DETECTION OF INACTIVATING MUTATIONS OF THE TUMOR SUPPRESSOR GENE p53 IN BLADDER TUMORS. The Journal of Urology, pages 1973-1975.
Crossref
Crossref
Haukaas, Dæhlin, Maartmann‐Moe & Ulvik. (2001) The long‐term outcome in patients with superficial transitional cell carcinoma of the bladder: a single‐institutional experience. BJU International 83:9, pages 957-963.
Crossref
Crossref
CHRISTIAN PFISTER, JEAN MICHEL FLAMAN, COSETTE MARTIN, PHILIPPE GRISE & THIERRY FREBOURG. (1999) SELECTIVE DETECTION OF INACTIVATING MUTATIONS OF THE TUMOR SUPPRESSOR GENE p53 IN BLADDER TUMORS. Journal of Urology 161:6, pages 1973-1975.
Crossref
Crossref
S.L. JOHANSSON, G. BORGHEDE & S. HOLMANG. (1999) MICROPAPILLARY BLADDER CARCINOMA: A CLINICOPATHOLOGICAL STUDY OF 20 CASES. Journal of Urology 161:6, pages 1798-1802.
Crossref
Crossref
PIERFRANCESCO BASSI, GIANLUCA DRAGO FERRANTE, NICOLA PIAZZA, RENATO SPINADIN, ROBERTO CARANDO, GIANLUIGI PAPPAGALLO & FRANCESCO PAGANO. (1999) PROGNOSTIC FACTORS OF OUTCOME AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER. The Journal of Urology, pages 1494-1497.
Crossref
Crossref
PIERFRANCESCO BASSI, GIANLUCA DRAGO FERRANTE, NICOLA PIAZZA, RENATO SPINADIN, ROBERTO CARANDO, GIANLUIGI PAPPAGALLO & FRANCESCO PAGANO. (1999) PROGNOSTIC FACTORS OF OUTCOME AFTER RADICAL CYSTECTOMY FOR BLADDER CANCER: A RETROSPECTIVE STUDY OF A HOMOGENEOUS PATIENT COHORT. Journal of Urology 161:5, pages 1494-1497.
Crossref
Crossref
Bell, Lydon, Kernick, Hong, Penn, Pocock & Stott. (2001) Contemporary results of radical radiotherapy for bladder transitional cell carcinoma in a district general hospital with cancer‐centre status. BJU International 83:6, pages 613-618.
Crossref
Crossref
S. Osawa, Y. Terashima, G. Kimura & M. Akimoto. (2008) Antitumour effects of the angiogenesis inhibitor AGM‐1470 on rat urinary bladder tumours induced by N‐butyl‐N‐(4‐hydroxybutyl) nitrosamine. BJU International 83:1, pages 123-128.
Crossref
Crossref
Jonathan I. Epstein, Mahul B. Amin, Victor R. Reuter & Fathollah K. Mostofi. (1998) The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary Bladder. The American Journal of Surgical Pathology 22:12, pages 1435-1448.
Crossref
Crossref
Mayfield & Whelan. (2002) Bladder tumours detected on screening: results at 7 years. British Journal of Urology 82:6, pages 825-828.
Crossref
Crossref
Stackl, Baierlein & Albrecht. (2002) Bladder preservation in muscle‐invasive bladder cancer. British Journal of Urology 82:3, pages 357-360.
Crossref
Crossref
Iczkowski Shanks & Bostwick. (2001) Loss of CD44 variant 6 expression differentiates small cell carcinoma of urinary bladder from urothelial (transitional cell) carcinoma. Histopathology 32:4, pages 322-327.
Crossref
Crossref
Sten HolmangHans HedelinGoran BorghedeSonny L. Johansson. (1997) Long-term Followup of a Bladder Carcinoma Cohort: Questionable Value of Radical Radiotherapy. Journal of Urology 157:5, pages 1642-1646.
Crossref
Crossref
Olof Alfthan, Kari Jauhiainen, Eero Kaasinen & Tapani Liukkonen. (1997) Current concepts in the role of intravesical instillations in the therapy and prophylaxis of superficial transitional-cell cancer of the bladder. World Journal of Urology 15:2, pages 89-95.
Crossref
Crossref
Yoshinori Tanaka, Hitoshi Kawamata, Kiyohide Fujimoto & Ryoichi Oyasu. (1997) Angiogenesis Inhibitor TNP-470 Suppresses Tumorigenesis In Rat Urinary Bladder. The Journal of Urology, pages 683-688.
Crossref
Crossref
Yoshinori TanakaHitoshi KawamataKiyohide FujimotoRyoichi Oyasu. (1997) Angiogenesis Inhibitor TNP-470 Suppresses Tumorigenesis In Rat Urinary Bladder. Journal of Urology 157:2, pages 683-688.
Crossref
Crossref
H. Rübben & T. Otto. 1997. Uroonkologie. Uroonkologie
85
178
.
M.P. RAITANEN, P. NIEMINEN & T.L.J. TAMMELA. (2008) Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder. British Journal of Urology 76:4, pages 470-474.
Crossref
Crossref
T. Kakizoe, WR Fair, PH Smith, F Algaba P Ferrari, HB Grossman, Z. Zirkali, T. Tsukamoto & M. Tachibana. (1995) WHAT IS THE BIOLOGY OF INVASION AND METASTASIS IN BLADDER CANCER?. International Journal of Urology 2:s2, pages 58-63.
Crossref
Crossref
D. Mack & J. Frick. (1995) Five-year results of a phase ii study with low-dose bacille calmette-guérin therapy in high-risk superficial bladder cancer. Urology 45:6, pages 958-961.
Crossref
Crossref
D. Schiavone, R. Pianon, L. Comunale & G. Mobilio. (2018)
I parametri clinici, endoscopici e patologici nella valutazione delle potenzialità evolutive dei tumori superficiali della vescica:
Clinical, endoscopic and pathological parameters in assessing the potential progression of superficial bladder tumours
. Urologia Journal 62:2, pages 168-183.
Crossref
Crossref
T Kakizoe (c)WR Fair (cc)PH Smith (cc)F Algaba P Ferrari, HB Grossman, Z Zirkali, T Tsukamoto & M Tachibana. (2007) WHAT IS THE BIOLOGY OF INVASION AND METASTASIS IN BLADDER CANCER?. International Journal of Urology 2:1, pages 58-63.
Crossref
Crossref
D. Mack & J. Frick. (2008) Low‐dose bacille Calmette‐Guerin (BCG) therapy in superficial high‐risk bladder cancer: a phase II study with the BCG strain Connaught Canada. British Journal of Urology 75:2, pages 185-187.
Crossref
Crossref
S.J. Harland. (1994) Aggressive superficial bladder cancer. European Journal of Cancer 30:7, pages 899-900.
Crossref
Crossref
H. Rübben & T. Otto. 1994. Uroonkologie. Uroonkologie
79
157
.
D. E. Neal. 1994. Tumours in Urology. Tumours in Urology
3
18
.
P. WHELAN, J. P. BRITTON & A. C. DOWELL. (2008)
Three‐year Follow‐up of Bladder Tumours found on Screening
. British Journal of Urology 72:6, pages 893-896.
Crossref
Crossref
Javier C. Angulo, Jose I. Lopez, Nicolas Flores & Juan D. Toledo. (1993) The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification. Journal of Cancer Research and Clinical Oncology 119:10, pages 578-593.
Crossref
Crossref
Harold A. Frazier, Judith E. Robertson, Richard K. Dodge & David F. Paulson. (1993) The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 71:12, pages 3993-4001.
Crossref
Crossref
A. BERNER, A.‐B. JACOBSEN, S. D. FOSSÅ & J. M. NESLAND. (2007) Expression of c‐erbB‐2 protein, neuron‐specific enolase and DNA flow cytometry in locally advanced transitional cell carcinoma of the urinary bladder. Histopathology 22:4, pages 327-333.
Crossref
Crossref
Tadao Kakizoe, Kenichi Tobisu, Takashi Mizutani, Masakazu Tsutsumi, Yoshinori Tanaka & Michi‐ie Sakamoto. (2005) Analysis by Step Sectioning of Early Invasive Bladder Cancer with Special Reference to G3·pT1 Disease. Japanese Journal of Cancer Research 83:12, pages 1354-1358.
Crossref
Crossref
Gary D. Steinberg, Donald L. Trump & Kenneth B. Cummings. (1992) METASTATIC BLADDER CANCER. Urologic Clinics of North America 19:4, pages 735-746.
Crossref
Crossref
George R. Prout, Bruce A. Barton, Pamela P. Griffin & Gilbert H. Friedell. (1992) Treated History of Noninvasive Grade 1 Transitional Cell Carcinoma. Journal of Urology 148:5 Part 1, pages 1413-1419.
Crossref
Crossref
Donald L. Lamm. (1992) LONG-TERM RESULTS OF INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER. Urologic Clinics of North America 19:3, pages 573-580.
Crossref
Crossref
Jae Y. Ro, Gregg A. Staerkel & Alberto G. Ayala. (1992) CYTOLOGIC AND HISTOLOGIC FEATURES OF SUPERFICIAL BLADDER CANCER. Urologic Clinics of North America 19:3, pages 435-453.
Crossref
Crossref
Niall M. Heney. (1992) NATURAL HISTORY OF SUPERFICIAL BLADDER CANCER. Urologic Clinics of North America 19:3, pages 429-433.
Crossref
Crossref
PER‐UNO MALMSTRÖM, KENNETH WESTER, JANOS VASKO & CHRISTER BUSCH. (2009) Expression of proliferative cell nuclear antigen (PCNA) in urinary bladder carcinoma. Evaluation of antigen retrieval methods. APMIS 100:7-12, pages 988-992.
Crossref
Crossref
Gregg R. Eure, Maria R. Cundiff & Paul F. Schellhammer. (1992) Bacillus Calmette-Guerin Therapy for High Risk Stage T1 Superficial Bladder Cancer. Journal of Urology 147:2, pages 376-379.
Crossref
Crossref
L. Samodai, L. Kiss, Z. Kolozsy & L. Mohácsi. (1991) The efficacy of intravesical BCG in the treatment of patients with high risk superficial bladder cancer. International Urology and Nephrology 23:6, pages 559-567.
Crossref
Crossref
P. -U. Malmstr�m, J. Vasko, K. Wester & C. Busch. (1991) Determination of DNA ploidy and ABH antigen reactivity in both frozen and formalin-fixed bladder tumor tissue. Urological Research 19:6, pages 357-359.
Crossref
Crossref
Sonja Kaubisch, Bert L. Lum, Jeffrey Reese, Fuad Freiha & Frank M. Torti. (1991) Stage T1 Bladder Cancer: Grade is the Primary Determinant for Risk of Muscle Invasion. Journal of Urology 146:1, pages 28-31.
Crossref
Crossref
Bengt-Erik Carbin, Peter Ekman, Hans Gustafson, Niels J. Christensen, Bengt Sandstedt & Claes Silfverswärd. (1991) Grading of Human Urothelial Carcinoma Based on Nuclear Atypia and Mitotic Frequency. II. Histological Description. Journal of Urology 145:5, pages 972-976.
Crossref
Crossref
Bengt-Erik Carbin, Peter Ekman, Hans Gustafson, Niels J. Christensen, Bengt Sandstedt & Claes Silfverswärd. (1991) Grading of Human Urothelial Carcinoma Based on Nuclear Atypia and Mitotic Frequency. I. Histological Description. Journal of Urology 145:5, pages 968-971.
Crossref
Crossref
C. Edward Blomjos, Winand Vos, Herman J. de Voogt, Paul Van Der Valk & Chris J. L. M. Meijer. (1989) Small cell carcinoma of the urinary bladder. A clinicopathologic, morphometric, immunohistochemical, and ultrastructural study of 18 cases. Cancer 64:6, pages 1347-1357.
Crossref
Crossref
B. R. P. BIRCH & S. J. HARLAND. (1989) The pT1 G3 Bladder Tumour. British Journal of Urology 64:2, pages 109-116.
Crossref
Crossref
PER‐UNO MALMSTRÖM, JANOS VASKO, KENNETH WESTER, BO JOHAN NORLÉN & CHRISTER BUSCH. (2009) Flow cytometric analysis of DNA content of deparaffinized nuclei in urinary bladder carcinomas. APMIS 97:7-12, pages 811-819.
Crossref
Crossref
P.‐U. MALMSTRÖM, B. J. NORLÉN, B. ANDERSSON & C. BUSCH. (2008) Combination of Blood Group ABH Antigen Status and DNA Ploidy as Independent Prognostic Factor in Transitional Cell Carcinoma of the Urinary Bladder. British Journal of Urology 64:1, pages 49-55.
Crossref
Crossref